LinkedInXFacebook
Subscribe
Orthopedics This Week
  • My Feed
  • |Posts
  • |Events
  • |MSK Innovations
  • |Power Rankings
  • |Masterclasses
  • |Technology Awards
  • Press Releases
  • |Advertising
  • |Job Board
  • Spine
  • ◆Joints
  • ◆Upper Extremities
  • ◆Foot & Ankle
  • ◆Sports Medicine
  • ◆Pain Mgmt
  • ◆Trauma
  • ◆Biologics
  • ◆Technology
  • ◆People
  • ◆Company News
  • ◆Legal & Regulatory
Home/Legal & Regulatory and Reimbursement/Key Provision of ‘No Surprises Act’ Put on Hold
Legal & Regulatory and Reimbursement

Key Provision of ‘No Surprises Act’ Put on Hold

March 1, 2023 1 min read Premium comments

Advertisement

Key Provision of ‘No Surprises Act’ Put on Hold
Photo creation by RRY Publications, LLC, The Centers for Medicare & Medicaid Services (CMS), Pixabay and StartupStockPhotos
#centersforMedicareandmedicaidservicesSecondary#independentdisputeresolution#nosurprisesact

A ruling from the U.S. District Courts for the Eastern District of Texas has prompted The Centers for Medicare & Medicaid Services (CMS) to temporarily suspend any decisions made by independent dispute resolution (IDR) entities.

The District Court order affects the independent dispute resolution process regarding payment disputes. The Texas Medical Association and other parties had filed the lawsuit due to the Final Rule issued under the No Surprises Act.

According to that order, the Final Rule “governs the arbitration process for resolving payment disputes between certain out-of-network providers and group health plans and health insurance issuers.” The Texas Medical Association and other parties had argued that the provisions of the Final Rule “improperly restrict arbitrators’ discretion and unlawfully tilt the arbitration process in favor of the QPA [qualifying payment amount].”

The Court agreed.

After the Court issued its opinion, CMS responded by saying: “As a result of the TMA II decision, the Departments are in the process of evaluating and updating Federal IDR process guidance, systems, and related documents to make them consistent with the TMA II decision. Effective immediately, certified IDR entities should not issue new payment determinations until receiving further guidance from the Departments. Certified IDR entities also should recall any payment determinations issued on or after February 6, 2023. Certified IDR entities should continue working through other parts of the IDR process as they wait for additional direction from the Departments.”

The Texas Medical Association, which has already filed four lawsuits is not holding back when voicing opposition to portions of the No Surprises Act. Most recently, the Texas Medical Association, joined by others, filed a lawsuit challenging a 600% increase in administrative fees for dispute resolution. For OTW’s coverage of the litigation, see “Texas Docs Sue Over No-Surprises-Act 600% Fee Increase.”

React:

Discussion

14
DS
Dr. Sarah MitchellOrthopedic Surgeon · Mayo Clinic

This is a fascinating development. In my practice we've seen similar outcomes with the revised protocol. The key differentiator seems to be patient selection criteria. Has anyone else noticed the correlation with BMI thresholds?

8
JT
James Thornton, MDSpine Fellow · HSS

Great point. I'd push back slightly on the conclusion, the sample size in the cited study is too small to draw population-level inferences. That said, the directional signal is compelling and worth a larger RCT.

5
RP
R. PatelSports Medicine · Stanford

We implemented a similar approach last year. Early results are promising but we're still gathering 12-month follow-up data. Happy to share our protocol if anyone is interested.

Join the conversation

Orthopedic professionals are discussing this. Sign in and upgrade to read every comment and add your voice.

Subscribe

Get Full Access

Read every OTW article and join member discussions for $24.99/month.

Get Full Access

Advertisement

Advertisement

Advertisement

Orthopedics This Week

The most trusted source in orthopedic industry news since 2005. Covering spine, joints, trauma, biologics, and the business of orthopedics.

A publication of RRY Publications, LLC

LinkedInXFacebook

Categories

  • Spine
  • Joints
  • Upper Extremities
  • Foot & Ankle
  • Sports Medicine
  • Pain Mgmt
  • Trauma
  • Biologics
  • Technology
  • People
  • Company News
  • Legal & Regulatory

Resources

  • Subscribe
  • Community Posts
  • Job Board
  • Press Release Opportunities
  • Power Rankings
  • About OTW
  • Advertise
  • Contact Us

Get Full Access

Unlimited articles, community posts, and Power Rankings.

Get Full Access

Plans start at $24.99/mo · Annual saves 20%

© 2026 Orthopedics This Week · RRY Publications, LLC

Privacy PolicyTerms of ServiceCookie Policy